&nbsp;

Nov 2024

Drug

CISplatin

Quick Link(s):

Nov 2024

Drug

cladribine

Other Name(s): Leustatin®

Quick Link(s):

Nov 2024

Drug

cabazitaxel

Other Name(s): Jevtana®

Quick Link(s):

Nov 2024

Drug

ceritinib

Other Name(s): Zykadia™

Quick Link(s):

Nov 2024

Drug

cobimetinib

Other Name(s): Cotellic™

Quick Link(s):

Nov 2024

Regimen

CISPDOXO

Cancer Type:

Sarcoma,

Osteogenic / Bone

Intent: Adjuvant, Neoadjuvant, Palliative

Drugs Used:

DOXOrubicin,

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CABAPRED

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

New Drug Funding Program

Cabazitaxel - Metastatic Castration Resistant Prostate Cancer

ODB - General Benefit

prednisone

Drugs Used:

cabazitaxel,

prednisone

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

CVP(PO)+R

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

ODB - General Benefit

prednisone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma

ODB - General Benefit

cyclophosphamide - oral tablets

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CISP

Cancer Type:

Gynecologic,

Cervix,

Endometrial,

Ovary,

Vulva

Intent: Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

CISP

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2024

Regimen

CISP

Cancer Type:

Unknown Primary

Intent: Palliative

Drugs Used: